COSENTYX
These highlights do not include all the information needed to use COSENTYX safely and effectively. See full prescribing information for COSENTYX. COSENTYX (secukinumab) injection, for subcutaneous or intravenous useInitial U.S. Approval: 2015
77c4b13e-7df3-42d4-81db-3d0cddb7f67a
HUMAN PRESCRIPTION DRUG LABEL
Jan 25, 2024
Novartis Pharmaceuticals Corporation
DUNS: 002147023
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
secukinumab
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (8)
secukinumab
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (8)
secukinumab
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (8)
secukinumab
Product Details
FDA regulatory identification and product classification information